Skip to content
Dose Brief
Menu
The shortlist

Alternatives to SkinnyRx

SkinnyRx sits at No. 356 in our ranking with a Brief Score of 58. Here are the GLP-1 providers we'd weigh against it — ranked on the same six-factor Brief Score, top down.

Prefer a straight head-to-head? CoreAge Rx vs SkinnyRx.

Our top alternative

No. 1 here

CoreAge Rx

CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

Coverage
US only; restrictions by state, confirmed at intake

More providers worth weighing

No. 19 · Grade B

Curex

86/100

Curex offers compounded injections and tablets, but its introductory offers, annual prices and refund promises need to be matched to the terms you accept.

Semaglutide

Confirm the selected offer

Rate sheet: $299 monthly or $2,388 annually ($199/mo equivalent).

Separate first-month offer from $49; renewal quote requires confirmation.

Full price details

Conflicting published offers: rate sheet $299/month or $2,388 annual prepayment ($199/mo equivalent); separate offer from $49 first month

Coverage
All 50 states advertised; California oral tablets only, no injections
Price trend
new to the tracker, no prior reading

FDA warning letter, September 2025 — issued to Curex. See the FDA's warning letter database.

No. 28 · Grade B

TeleCareSpot

85/100

TeleCareSpot publishes monthly medication programs and state exclusions, but its refund terms still contain unedited sample-policy language.

Semaglutide

From $299/mo

Monthly supply if prescribed; support and delivery where available. Confirm any separate consultation charge.

Full price details

From $299/month; monthly supply if prescribed, support and delivery where available

Coverage
Excludes Alaska, Mississippi and New Jersey; confirm selected treatment eligibility
Price trend
price stable
No. 49 · Grade B−

Apex MD

80/100

Apex MD includes quarterly bloodwork and provider access with its GLP-1 plans; check renewal terms and distinguish advertised tracking from proven outcomes.

Semaglutide

$299/mo compounded program

Advertised quarterly bloodwork and provider access included; confirm selected preparation.

Full price details

$299/mo compounded semaglutide program; prescribed doses, quarterly bloodwork and provider access included

Coverage
Confirm medication and clinician availability for your state
Price trend
new to the tracker, no prior reading
No. 98 · Grade C

ZYP Medical

75/100

ZYP Medical offers direct contact with a named nurse practitioner across seven states, with prepaid starter supplies and dose-dependent refill pricing.

Semaglutide

Starter: $399 for 10 weeks

Paid upfront. Displayed $160 equivalent is not a calendar-month renewal quote; refills vary by dose.

Full price details

Calendar-month quote unknown; compounded semaglutide starter is $399 upfront for 10 weeks; refill price depends on dose

Coverage
Nebraska, Iowa, South Dakota, Minnesota, Kansas, Colorado and Arizona; confirm patient-location eligibility
Price trend
new to the tracker, no prior reading
No. 150 · Grade C

MyStart Health

71/100

MyStart advertises an inclusive GLP-1 program with automatic refills, but its generic starting price does not establish separate current quotes for both medications.

Semaglutide

Confirm a named-drug quote

Generic program starts at $299/mo; a current semaglutide quote is not established. Automatic billing depends on the selected plan.

Full price details

Current named semaglutide offer and complete quote unknown; generic program starts $299/month; earlier listing: From $299/mo (all doses, compounded)

Coverage
Current medication-specific state availability requires confirmation; reviewed public pages did not establish a complete service roster
Price trend
new to the tracker, no prior reading

FDA warning letter, September 2025 — issued to Matthew Stern, CEO MyStart Health LLC.. See the FDA's warning letter database.

No. 185 · Grade C

MEDGm

66/100

MEDGm publishes first-month discounts and prepaid tiers; the renewal amount and cancellation restrictions matter more than the introductory headline.

Semaglutide

$299/mo monthly ($179 first month with advertised coupon); $199/mo on 3 months ($597), $189/mo on 6 ($1,134), $169/mo on 12 ($2,028 prepaid)

Coverage
All 50 states and D.C.
Price trend
new to the tracker, no prior reading
No. 251 · Grade C

Willow

66/100

Compounded injection and sublingual GLP-1 programs with dose-dependent pricing and an automatic-renewal cancellation deadline.

Semaglutide

$299/mo for listed standard injection tiers or sublingual tablet; higher injection tier listed at $399/mo

Coverage
36 states listed by the provider; confirm your treatment and address
Price trend
new to the tracker, no prior reading
No. 157 · Grade C

Rex MD

71/100

Rex MD advertises Wegovy pill medication and care together, while other formulations and subscriptions require their own quote.

Semaglutide

Confirm the Wegovy pill agreement

Advertised from $349/month for the Wegovy pill and provider care; injectable Wegovy needs its own quote.

Full price details

Brand Wegovy pill offered; complete selected agreement and injectable quote unknown; advertised pill medication and care from $349/month; earlier listing: From $199/mo (brand-name)

Coverage
Selected treatment availability depends on patient location, clinician licensing and pharmacy eligibility; confirm your state
Price trend
new to the tracker, no prior reading

On the record

The FDA issued a warning letter to Lean Rx, Inc. dba SkinnyRx in February 2026. Read the letter in the FDA's warning letter database for the agency's findings.

Rankings reflect the Dose Brief Score — our editorial judgment per the methodology. Pricing and coverage reflect public disclosures at last review and change often — confirm on each provider's site. Not medical advice; see our disclosure.